Nuhenz tablet contains mecobalamin, alpha lipoic acid, benfotiamine, folic acid, chromium polynicotinate, myo-inositol and pyridoxine hydrochloride. Nuhenz tablet is indicated in CVDs, Diabetic retinopathy, Diabetic nephropathy and Diabetic nephropathy.
Benfotiamine increases transketolase activity, that can in turn decreases the buildup of detrimental glucose metabolites that can lead to advanced glycation end products (AGE), which may lead to diabetic complications. Benfotiamine also prevents diabetic retinopathy.
Benfotiamine and alpha-lipoic acid should be considered as first choices among pathogenetically oriented treatments of diabetic neuropathy.
Mecobalmain, Pyridoxine, Folic acid and Myo-inositol act as potent antioxidants that reduce number of free radicals and reduces the risk of complications associated with Diabetes.